Cambridge Healthtech Institute’s 7th Annual

Advancing Bispecific Antibodies and Combination Therapy to the Clinic
( 进入临床阶段的双特异性抗体和并用疗法 )

Creating the Killer Combo

2019年4月10~11日

 

One of the leading areas of antibody research is bispecific antibodies. The Seventh Annual Advancing Bispecific Antibodies and Combination Therapy to the Clinic conference will review recent preclinical and clinical results on a variety of bispecific and multi-specific constructs. Thought leaders in the community will review progress and discuss the best strategies for improving targeting, safety and efficacy for applications in immuno-oncology, oncology, CNS and infectious disease.

 

Coverage will include, but is not limited to:

 

  • Review clinical and preclinical data from antibodies in development
  • Select bispecific combinations and combination therapy – finding the best format works for your application
  • Assess stability, functionality, safety, potency and biodistribution of novel engineered formats
  • Determine strategies for T cell and checkpoint inhibitor targeting
  • Expand applications beyond oncology to CNS, infectious disease, transplantation and beyond

 

* 活动内容有可能不事先告知作更动及调整。

Choose your language
Chinese
Japanese
Korean
English





显示切换



免费电子邮件通知服务